VOXERALGAGENE AUTOTEMCEL
UNII RZ8DCR7A94

Substance Identification & Data

This profile provides standardized clinical and technical data for Voxeralgagene Autotemcel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RZ8DCR7A94.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RZ8DCR7A94

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VOXERALGAGENE AUTOTEMCEL

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C188780

National Cancer Institute reference terminology for clinical and research data.

INN ID

11441

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-71

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

180092

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

9606

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Voxeralgagene Autotemcel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VOXERALGAGENE AUTOTEMCEL

Common Names & Synonyms

AUTOLOGOUS CD34+ HEMATOPOIETIC STEM CELLS (HSCS) TRANSDUCED EX VIVO WITH A SELF-INACTIVATING LENTIVIRAL VECTOR ENCODING HUMAN ALPHA-GALACTOSIDASE A (GLA). AUTOLOGOUS CD34+ HEMATOPOIETIC STEM CELLS (HSCS) OBTAINED BY APHERESIS, TRANSDUCED WITH A NON-REPLICATING, SELF-INACTIVATING LENTIVIRAL VECTOR ENCODING CODON-OPTIMIZED HUMAN ALPHAGALACTOSIDASE A (GLA) UNDER THE CONTROL OF THE HUMAN ELONGATION FACTOR 1 ALPHA SHORT (EFS-1 ALPHA) PROMOTER AND A MODIFIED WOODCHUCK HEPATITIS VIRUS POST-TRANSCRIPTIONAL REGULATORY ELEMENT (WPRE). THE VECTOR GENOME ALSO CONTAINS A PACKAGING SIGNAL, A PARTIAL GAG SEQUENCE, A REV RESPONSE ELEMENT (RRE), A CENTRAL POLYPURINE TRACT (CPPT) AND A KOZAK SEQUENCE. CELL-BASED GENE THERAPY

VOXERALGAGENE AUTOTEMCEL [INN]

VOXERALGAGENE AUTOTEMCEL [USAN]

Technical Codes

AVR-RD-01

External Clinical & Regulatory Resources

Previous UNIIRZ79Q794ZF

Next UNIIRZ8K60YAFB